Zeba Siddiqui

(Reuters) - Vivus Inc, vying to create the world's first billion-dollar weight-loss pill, is taking a cautious approach to marketing in an attempt to overcome the skepticism, safety concerns and...

(Reuters) - Embattled healthcare technology firm Allscripts named its board member and former chief operating officer of rival Cerner Corp Paul Black as its CEO, replacing Glen Tullman, and said...

(Reuters) - Embattled healthcare technology firm Allscripts named its board member and former chief operating officer of rival Cerner Corp Paul Black as its CEO, replacing Glen Tullman, and said...

(Reuters) - Chelsea Therapeutics International Ltd said U.S. health regulators recommended an additional trial for its rejected hypotension drug Northera, further delaying the launch of the treatment and sending its...

(Reuters) - Chelsea Therapeutics International Ltd said U.S. health regulators recommended an additional trial for its rejected hypotension drug Northera, further delaying the launch of the treatment and sending its...

(Reuters) - Peregrine Pharmaceuticals Inc said results from a mid-stage trial showed that its key experimental drug performed better than standard chemotherapy in lung cancer patients who had not responded...

(Reuters) - InterMune Inc said French health authorities ruled in favor of reimbursing the company's lung scarring drug Esbriet, potentially covering its costs in a country that is scaling back...

(Reuters) - InterMune Inc said French health authorities ruled in favor of reimbursing the company's lung scarring drug Esbriet, potentially covering its costs in a country that is scaling back...